A major ocean current in the Arctic, the Beaufort Gyre, is changing rapidly due to climate warming—and this could trigger a ...

Gyre Therapeutics' stock is volatile - I'm upholding ... from five main classes of drugs aiming to reach the market in the current MASH landscape: Farnesoid X receptor agonists, fibroblast grow ...

Gyre Therapeutics, Inc. (NASDAQ:GYRE – Get Free Report)’s stock price gapped down prior to trading on Tuesday following a weaker than expected earnings announcement. The stock had previously ...

In a report released today, Robert LeBoyer from Noble Financial reiterated a Buy rating on Gyre Therapeutics (GYRE – Research Report), with a price target of $20.00. The company’s shares ...

Earnings per share (EPS) missed analyst estimates by 71%. In the last 12 months, the only revenue segment was Gyre Pharmaceuticals contributing US$105.8m. The largest operating expense was Sales ...

Award-winning distillery Gyre & Gimble has announced the launch of Curious Whiskies, an exclusive collection of single cask bottlings and an Islay peated blend, to celebrate the very best of Scotch ...